These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 4282933)

  • 1. [Virulence and immunogenicity of a modified vaccinia virus (strain MVA) (author's transl)].
    Hochstein-Mintzel V; Huber HC; Stickl H
    Z Immunitatsforsch Exp Klin Immunol; 1972 Sep; 144(2):104-56. PubMed ID: 4282933
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the mode of inhibition of vaccinial dermal lesions in rabbit.
    Prasad CB
    Indian J Pathol Microbiol; 1979 Jan; 22(1):71-4. PubMed ID: 94591
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the specificity of the intracutaneous test with vaccinia antigen (author's transl)].
    Habs H; Quincke G
    Z Immunitatsforsch Exp Klin Immunol; 1972 Mar; 143(2):175-83. PubMed ID: 4143078
    [No Abstract]   [Full Text] [Related]  

  • 4. Protection induced in mice against a lethal orthopox virus by the Lister strain of vaccinia virus and modified vaccinia virus Ankara (MVA).
    Abdalrhman I; Gurt I; Katz E
    Vaccine; 2006 May; 24(19):4152-60. PubMed ID: 16603280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Oral immunization with vaccinia-virus against mouse-pox (author's transl)].
    Munz E; Reimann M; Hoffmann R; Göbel E
    Zentralbl Bakteriol Orig B; 1974 Apr; 159(1):10-30. PubMed ID: 4369631
    [No Abstract]   [Full Text] [Related]  

  • 6. Identification and preliminary characterization of vaccinia virus (Dryvax) antigens recognized by vaccinia immune globulin.
    Jones-Trower A; Garcia A; Meseda CA; He Y; Weiss C; Kumar A; Weir JP; Merchlinsky M
    Virology; 2005 Dec; 343(1):128-40. PubMed ID: 16165184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model.
    Meseda CA; Garcia AD; Kumar A; Mayer AE; Manischewitz J; King LR; Golding H; Merchlinsky M; Weir JP
    Virology; 2005 Sep; 339(2):164-75. PubMed ID: 15993917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge.
    Wyatt LS; Earl PL; Eller LA; Moss B
    Proc Natl Acad Sci U S A; 2004 Mar; 101(13):4590-5. PubMed ID: 15070762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of ethyl alcohol and beta-propiolactone inactivated vaccinia virus on the development of skin immunity and the production of hemagglutination inhibiting antibodies in guinea pigs, rabbits and monkeys.
    Lybing S; Hedström KG
    Z Immunitatsforsch Exp Klin Immunol; 1975 May; 149(1):37-60. PubMed ID: 127456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of various virulence tests with low virulence vaccinia virus in mice.
    Ludvíková V; Kutinová L; Simonová V; Otavová M
    Biologicals; 1994 Jun; 22(2):187-90. PubMed ID: 7917234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effectiveness of immunization with vaccinia virus type "MVA" against an infection with cowpox virus type "OPV 85" in rabbits].
    Munz E; Linckh S; Renner-Müller IC; Reimann M
    Zentralbl Veterinarmed B; 1993 Mar; 40(2):131-40. PubMed ID: 8322545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Oral and nasal immunization with Poxvirus vacciniae. 3. Animal experiments].
    Hochstein-Mintzel V; Huber HC; Stickl H
    Zentralbl Bakteriol Orig B; 1972 Aug; 156(1):30-96. PubMed ID: 4200246
    [No Abstract]   [Full Text] [Related]  

  • 13. Pathogenicity and immunogenicity of recombinant Tiantan Vaccinia Virus with deleted C12L and A53R genes.
    Dai K; Liu Y; Liu M; Xu J; Huang W; Huang X; Liu L; Wan Y; Hao Y; Shao Y
    Vaccine; 2008 Sep; 26(39):5062-71. PubMed ID: 18573290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Animal experimental studies on oral immunization with vaccinia virus. I].
    Hochstein-Mintzel V; Huber H; Stickl H
    Zentralbl Bakteriol Orig; 1969 Dec; 212(1):41-9. PubMed ID: 5386253
    [No Abstract]   [Full Text] [Related]  

  • 15. Generation and evaluation of a recombinant modified vaccinia virus Ankara vaccine for rabies.
    Weyer J; Rupprecht CE; Mans J; Viljoen GJ; Nel LH
    Vaccine; 2007 May; 25(21):4213-22. PubMed ID: 17434244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenicity and immunogenicity in mice of vaccinia viruses mutated in the viral envelope proteins A33R and B5R.
    Gurt I; Abdalrhman I; Katz E
    Antiviral Res; 2006 Mar; 69(3):158-64. PubMed ID: 16406098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behaviour of the typhoid vaccine intradermally administered in association with tetanus unadsorbed vaccine and soluble antigens of vaccinia virus.
    Croitoru M; Dimache G; Mihăilescu R; Velea V; Durbacă S; Stoean C
    Arch Roum Pathol Exp Microbiol; 1988; 47(2):139-43. PubMed ID: 3250365
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunogenicity of smallpox vaccines prepared from strains of different reactogenicity.
    Nyerges G; Csukás M
    Acta Microbiol Acad Sci Hung; 1972; 19(2):103-9. PubMed ID: 4670218
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on different strains of vaccinia virus with particular reference to their quality regarding immunogenicity and reactogenicity. 3. Studies in rabbits and monkeys (Macaca mulatta).
    Sehgal CL; Suri NK; Choudhury S; Murty DK; Raghavan NG
    Indian J Med Res; 1973 Sep; 61(9):1265-74. PubMed ID: 4205143
    [No Abstract]   [Full Text] [Related]  

  • 20. Temperature mutants and recombinants of vaccinia virus. I. Genetic characteristics of temperature mutants.
    Fidziańska E
    Acta Virol; 1972 Jul; 16(4):291-7. PubMed ID: 4403170
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.